Home›Companies›Biotech & Pharma›Stabilux Biosciences

Stabilux Biosciences, Inc.

Updated Oct 29, 2026·Latest SEC filing May 16, 2024·Suggest an edit

About Stabilux Biosciences

Stabilux Biosciences is a private company based in Ann Arbor, Michigan. It has reported $554,381 raised in one offering on Form D since May 2024.

Funding Rounds (SEC Form D)

First saleFiled with SECAmount soldInvestorsAvg. checkTermsFiling
Apr 24, 2024May 16, 2024$554,381of $3.0M target9$61,598Equity, OptionsRule 506(b)Form D ↗

First sale is the date the first investor in the offering committed to invest. Companies must file Form D within 15 days of that date, so filing dates run later.

Leadership Team

Executive officers and directors listed on Stabilux Biosciences's Form D filed May 16, 2024.

JL
Jonathan Leinonen
Executive officer and director
YY
Yoke Yap
President and director
MM
Michael Mortlock
Executive officer
ME
Mark Ehlert
Director
ST
Steve Tokarz
Executive officer and director
JR
John Ransom
Director

Sources

  1. SECSTABILUX BIOSCIENCES, INC. filing history